-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

632A.O2.6 632. Chronic Myeloid Leukemia: Therapy: Clinical and Molecular Predictors of Outcomes and Toxicities

Chronic Myeloid Leukemia: Therapy Program: Oral and Poster Abstracts
Type: Oral
Monday, December 7, 2015: 10:30 AM-12:00 PM
Valencia BC (W415BC), Level 4 (Orange County Convention Center)
Moderators:
Elisabetta Abruzzese, MD, S. Eugenio Hospital and Michael W Deininger, MD, PhD, The University of Utah, Division of Hematology and Hematologic Malignancies

Disclosures:
Abruzzese: BMS, Novartis, Pfizer, Ariad: Consultancy .
10:30 AM

Markus Pfirrmann1*, Joerg Hasford, MD1*, Susanne Saussele2, Anna Turkina, Prof., MD3, Witold Prejzner, MD4*, Juan Luis Steegmann, MD5, Bengt Simonsson, MD6*, Andrey Zaritskey, MD7*, Adriana Colita, MD8*, Daniela Zackova, MD9*, Jeroen Janssen, MD10, Francisco Cervantes11, Karel Indrak, MD12*, Joelle Guilhot, PhD13, Ruediger Hehlmann, MD2 and Michele Baccarani, MD14

1Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität München, Munich, Germany
2Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany
3National Research Center for Hematology, Moscow, Russia
4Department of Hematology, Medical University of Gdansk, Gdansk, Poland
5Department of Hematology, Hospital Universitario de la Princesa, Madrid, Spain
6Dept. Hematology, University Hospital, Uppsala, Sweden
7St Petersburg State Medical University, St Petersburg, Russia
8Fundeni Clinical Institute, Federation Center of Hematology and Bone Marrow Transplantation, Bucharest, Romania
9Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, and Masaryk University, Brno, Czech Republic
10Department of Hematology, VU University Medical Center, Amsterdam, Netherlands
11Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain
12Department of Hemato-oncology, University Palackianae, Olomouc, Czech Republic
13Clinical Investigation Center, INSERM CIC 1402, CHU de Poitiers, Poitiers, France
14Clinical Department of Hematology and Oncology L. and A. Seragnoli, S Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy

10:45 AM

Chung Hoow Kok, PhD1,2*, Tamara M Leclercq, PhD1,2*, Dale Watkins, PhD1,2*, David T Yeung, BSc, MBBS, FRACP, FRCPA2,3,4,5, Verity A Saunders, BSc (Hons)1*, Deborah L White, PhD, FFSc (RCPA)1,2,5 and Timothy P. Hughes, MD, MBBS, FRACP, FRCPA1,2,4,5

1Cancer Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, Australia
2School of Medicine, University of Adelaide, Adelaide, Australia
3Centre for Cancer Biology, SA Pathology, Adelaide, Australia
4Department of Haematology, SA Pathology, Adelaide, Australia
5Australasian Leukaemia and Lymphoma Group (ALLG), Melbourne, Australia

11:00 AM

Massimiliano Bonifacio, MD1*, Luigi Scaffidi1*, Gianni Binotto2*, Federico De Marchi3*, Elena Maino4*, Elisabetta Calistri5*, Angela Bonalumi1*, Luca Frison2*, Luciana Marin3*, Marta Medeot3*, Giovanna De Matteis6*, Renato Fanin3, Gianpietro Semenzato2*, Achille Ambrosetti1* and Mario Tiribelli, MD3*

1Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
2Department of Medicine, Hematology and Clinical Immunology, Padua School of Medicine, Padova, Italy
3Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy
4Hematology Unit, Ospedale Dell'Angelo, Venezia-Mestre, Venezia-Mestre, Italy
5Hematology Unit, Ospedale Ca' Foncello, Treviso, Treviso, Italy
6Department of Life and Reproduction Sciences, Section of Clinical Biochemistry, University of Verona, Verona, Italy

11:15 AM

Preetesh Jain, MBBS, MD, DM, PhD1,2*, Hagop M. Kantarjian, MD3, Raja Luthra, PhD4*, Graciela Nogueras Gonzalez5*, Elias Jabbour3, Koji Sasaki, MD6, Carlos Guillermo Romo, MD7*, Keyur P. Patel, MD, PhD4*, Tapan Kadia, MD3, Gautam Borthakur, MD3, Zeev Estrov, MD3, Farhad Ravandi, MD3, Susan O'Brien, MD3 and Jorge E. Cortes, MD8

1Internal Medicine, University of Texas, Houston
2Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
5Biostatistics, University of Texas, The MD Anderson Cancer Center, Houston, TX
6Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
7University of Texas, The MD Anderson Cancer Center, Houston
8Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

11:30 AM

Andreas Burchert, MD1, Sabrina Inselmann2*, Susanne Saussele3, Christian T. Dietz, PhD4*, Martin C. Müller, MD5*, Ekkehard Eigendorff, MD6*, Tim H. Brümmendorf, Prof MD7*, Cornelius Waller, MD8*, Jolanta Dengler, MD9*, Maria Elisabeth Goebeler, MD10*, Regina Herbst, MD11*, Gernot Freunek, MD12*, Stefan Hanzel, MD13*, Thomas Illmer, MD14, Ying Wang, MD15*, Andreas Neubauer, MD16, Thoralf Lange, MD17,18*, Andreas Hochhaus, MD6, Finkernagel Florian19*, Cornelia A. Brendel, MD20*, Joelle Guilhot, PhD21,22,23, Francois Xavier Mahon, MD, PhD24 and Christin Schütz25*

1Department of Hematology, Oncology and Immunology, Universitätsklinikum Giessen und Marburg, Marburg, Germany
2Universitaetsklinikum Giessen und Marburg GmbH, Marburg, Germany
3Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany
4III. Medizinische Klinik, Medizinische Fakultät Mannheim der Ruprechts-Karl-Universität Heidelberg, Mannheim, Germany
5Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Germany
6Department of Hematology and Oncology, University Hospital Jena, Jena, Germany
7Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, RWTH Aachen University Hospital, Aachen, Germany
8Department of Hematology and Oncology, University Hospital Freiburg, Freiburg, Germany
9Onkologische Praxis Heilbronn, Heilbronn, Germany
10University Hospital Würzburg, Würzburg, Germany
11Klinikum Chemnitz, Chemnitz, Germany
12MVZ Klinikum Straubing GmbH, Straubing, Germany
13Klinikum Kempten-Oberallgäu gGmbH, Kempten, Germany
14BAG Freiberg-Richter, Jacobasch, Wolf, Illmer, Dresden, Germany
15Department of Hematology and Oncology, Universitätsklinikum Giessen und Marburg, Marburg, Germany
16Dept. Hematology, Oncology, Immunology, Philipps University of Marburg, Medical Center of the University Giessen and Marburg, Marburg, Germany
17Asklepios Klinikum Weißenfels, Weißenfels, Germany
18Abteilung für Hämatologie/Onkologie, Universität Leipzig, Leipzig, Germany
19Philipps University Marburg, Marburg, Germany
20Klinik für Hämatologie, Onkologie und Immunologie, Universitätsklinikum Giessen und Marburg, Marburg, Germany
21Clinical Investigation Center, INSERM CIC 1402, CHU de Poitiers, Poitiers, France
22Inserm CIC 1402, University Hospital, Poitiers, France
23INSERM CIC 1402, CHU Poitiers, Poitiers, France
24Hematology Laboratory, Bordeaux University,Bordeaux Hospital, INSERM 1035, BORDEAUX, France
25Universitätsklinikum Giessen und Marburg, Marburg, Germany

11:45 AM

Susan Branford, PhD FFSc (RCPA)1, Paul PS Wang, PhD2*, Wendy Tara Parker, PhD3*, David Yeung2*, Justine E Marum, PhD2*, Doris Stangl, PhD2*, Zoe Donaldson2*, Alexandra Yeoman2*, Nathalie Nataren4*, Ieuan Walker5*, Leanne Purins2*, Bradley Chereda, PhD2*, Christopher N Hahn, PhD6*, Hamish S Scott, BSc, PhD, FFSc (RCPA)7, Andreas Schreiber, PhD2* and Timothy P. Hughes, MD, MBBS, FRACP, FRCPA8

1Centre for Cancer Biology, SA Pathology, University of Adelaide, Adelaide, Australia
2Centre for Cancer Biology, SA Pathology, Adelaide, Australia
3SA Pathology, Adelaide, Australia
4Centre for Cancer Biology, SA Pathology, University of South Australia, Adelaide, Australia
5King's College London, London, United Kingdom
6Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia
7Centre for Cancer Biology, University of South Australia, Adelaide, Australia
8SA Pathology and South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia

*signifies non-member of ASH